Does Dr. DOUGLAS CUNNINGHAM have financial conflicts of interest?

Dr. DOUGLAS CUNNINGHAM (D.O.) has received a total of $1,065,590 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $1,063,752 in personal promotional payouts (consulting, meals, travel) and $1,838 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. DOUGLAS CUNNINGHAM?

According to CMS Open Payments data, Dr. DOUGLAS CUNNINGHAM received funding from VIIV HEALTHCARE COMPANY ($537,925), GILEAD SCIENCES ($225,176), and JANSSEN PRODUCTS ($203,654).

Does Dr. DOUGLAS CUNNINGHAM receive research grants or speaking fees?

Dr. DOUGLAS CUNNINGHAM has received $1,063,752 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $1,838 in clinical research grants.

DR. DOUGLAS CUNNINGHAM

D.O.Real-Time Hydrated

Specialty: Family Medicine

Practice Location: PHOENIX, AZ 85015

NPI Number: 1104856475

LIFETIME INDUSTRY VALUE

$1,065,590

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. CUNNINGHAM is a verified Family Medicine practitioner based in PHOENIX, AZ.

Between 2021 and 2024, Dr. CUNNINGHAM had an overall industry promotional and research financial footprint of $1,065,590 as recorded in the federal CMS Open Payments database.

$1,063,752 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$1,838 was allocated to sponsored clinical trials and medical research activities.

Dr. CUNNINGHAM's primary funding source is VIIV HEALTHCARE COMPANY, which accounts for $537,925 (representing 50.5% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

VIIV HEALTHCARE COMPANY

Rank 1

$537,925

50.5%

GILEAD SCIENCES

Rank 2

$225,176

21.1%

JANSSEN PRODUCTS

Rank 3

$203,654

19.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.